Testosterone therapy may change how other drugs work in the body

NCT ID NCT05116293

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how gender-affirming testosterone therapy changes the way the body processes other medications. Fourteen transgender adults who were about to start testosterone therapy took small doses of three common drugs (midazolam, digoxin, and acetaminophen) before and after starting testosterone. Researchers measured drug levels in the blood to see if testosterone altered how these drugs were absorbed and broken down. The goal is to help ensure safe and effective dosing for transgender individuals on hormone therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
testosterone therapy
What this could lead to
If successful, this could help doctors adjust medication doses for transgender individuals on testosterone therapy, improving treatment safety and effectiveness.
What could go wrong
This is a very small, early-stage study with only 14 participants, so results may not apply to everyone. It only looks at how the body processes drugs, not whether testosterone therapy itself is safe or effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSGENDER PERSONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Washington

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.